Vimarsana
Biggest News Aggregation in the World

Page 25 - Depression Scale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Depression Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Depression Scale Today - Breaking & Trending Today

Sanofi - Aventis Groupe: Press Release: Dupixent (dupilumab) approved by European Commission as the first and only targeted medicine indicated for prurigo nodularis - Vimarsana News

Sanofi - Aventis Groupe: Press Release: Dupixent (dupilumab) approved by European Commission as the first and only targeted medicine indicated for prurigo nodularis

Dupixent (dupilumab) approved by European Commission as the first and only targeted medicine indicated for prurigo nodularis Approval based on direct-to-Phase 3 program showing

European Commission approves first medicine for prurigo nodularis - Vimarsana News

European Commission approves first medicine for prurigo nodularis

Dupixent®, the first and only targeted medicine for prurigo nodularis (PN) has been approved by the EC for adults with moderate-to-severe PN.

Risk of depression, anxiety, and stress among the Saudi general population during the COVID-19 pandemic | BMC Psychology - Vimarsana News

Risk of depression, anxiety, and stress among the Saudi general population during the COVID-19 pandemic | BMC Psychology

Promoting mental health and wellness is crucial for healthy communities. This study aims to assess the vulnerability of experiencing psychological reactions such as depression, anxiety, and stress within the general population in Saudi Arabia during the COVID-19 pandemic. A cross-sectional online survey was completed by 754 participants recruited from thirteen regions of Saudi Arabia. The information on background variables was obtained by using a set of close-ended questions. The DASS-21, a screening tool was used to assess the risk of depression, anxiety, and stress. Pie-chart displayed the ...

Coping Strategies Linked to Distress, QOL in Caregivers of Stem Cell Recipients - Vimarsana News

Coping Strategies Linked to Distress, QOL in Caregivers of Stem Cell Recipients

For caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT), coping is related to psychological distress and quality of life (QOL).

Coping Strategies Linked to Distress, QOL in Caregivers of Stem Cell Recipients - Vimarsana News

Coping Strategies Linked to Distress, QOL in Caregivers of Stem Cell Recipients

TUESDAY, Nov. 29, 2022 (HealthDay News) -- For caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT), coping is related to psychological distress and quality of life

Source: vtcng.com